Genenta Science S.p.A.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Operating Revenue $0 $0 $0 $0 $0
Research And Development $3.7m $4.7m $3.4m $5.3m $6.5m $4.8m $2.7m $2.7m
General and Administrative Expense $922k $902k $2.3m $5.7m $5.3m $5.0m $3.9m $3.9m
Operating Lease, Expense $14k $14k
Operating Expenses $4.6m $5.6m $5.7m $11.0m $11.7m $9.8m $6.6m $6.6m
Loss from operations ($4.6m)
($5.6m) -20.88%
($5.7m) -1.74%
($11.0m) -94.19%
($11.7m) -6.24%
($9.8m) +16.78%
($6.6m) +32.37%
Operating Income (Loss) ($4.6m)
($5.6m) -20.88%
($5.7m) -1.74%
($11.0m) -94.19%
($11.7m) -6.24%
($9.8m) +16.78%
($6.6m) +32.37%
($6.6m) 0.00%
Interest Income ($10k) ($8k) ($12k) $37k $309k $81k $609k $609k
Foreign Currency Transaction Gain (Loss), before Tax ($32k)
Foreign Currency Transaction Gain (Loss), Realized $1.6m
Gain On Sale Of Security $2.3m ($217k) $241k ($546k) ($546k)
Other Nonoperating Income (Expense) $6k $20k $243k ($5k) $530k $11k
Non-Operating Income (Expense) $36k $6k $20k $243k ($217k) $241k ($546k)
Other Income Expense $2.5m ($222k) $771k ($535k) ($535k)
Total other income, net $27k ($2k) $158k $2.6m $87k $852k $74k
Loss before income taxes ($4.6m) ($5.6m) ($5.5m) ($8.5m) ($11.6m) ($8.9m) ($6.5m)
Pre-Tax Income ($4.6m) ($5.6m) ($5.5m) ($8.5m) ($11.6m) ($8.9m) ($6.5m) ($6.5m)
Net loss ($4.6m) ($5.6m) ($5.5m) ($8.5m) ($11.6m) ($8.9m) ($6.5m)
Net Income From Continuing And Discontinued Operation ($4.6m) ($5.6m) ($5.5m) ($8.5m) ($11.6m) ($8.9m) ($6.5m) ($6.5m)
Earnings Per Share, Basic ($0.37) ($0.47) ($0.64) ($0.49) ($0.33) ($0.33)
Earnings Per Share, Diluted ($0.37) ($0.47) ($0.64) ($0.49) ($0.33) ($0.33)
Weighted Average Number of Shares Outstanding, Basic 15.1m 18.2m 18.2m 18.3m 19.7m 19.7m
Weighted Average Shares Outstanding, Diluted 15.1m 18.2m 18.2m 18.3m 19.7m
Basic Average Shares 15.1m $18.2m $18.2m $18.3m $19.7m $19.7m
Diluted Average Shares 15.1m $18.2m $18.2m $18.3m $19.7m $19.7m
Weighted Average Number of Shares Outstanding, Diluted 18.2m 18.3m 19.7m 19.7m
Additional Financial Items
Realized Investment Gains (Losses) $400k
Total $3.7m $4.7m $3.4m $5.3m $6.5m $4.8m $2.7m $0
Finance income ($10k) ($8k) ($12k) $37k $309k $81k $609k
Change in foreign currency translation ($16k) ($23k) $70k
Comprehensive loss ($4.6m) ($5.6m) ($5.5m) ($8.5m) ($11.4m) ($9.1m) ($6.5m)
Diluted EPS ($0.37) ($0.47) ($0.64) ($0.49) ($0.33) ($0.33)
Diluted NI Availto Com Stockholders ($4.6m) ($5.6m) ($5.5m) ($8.5m) ($11.6m) ($8.9m) ($6.5m) ($6.5m)
Insurance And Claims $1.3m $22k $18k $21k $21k
Normalized EBITDA ($13.3m) ($11.5m) ($10.0m) ($6.0m) ($6.6m)
Normalized Income ($10.8m) ($11.4m) ($9.2m) ($6.0m) ($6.0m)
Other Gand A $1.9m $2.7m $2.5m $1.9m
Reconciled Depreciation $6k $42k $45k $28k $28k
Salaries And Wages $2.6m $2.5m $2.5m $2.0m $2.0m
Selling General And Administration $922k $902k $2.3m $5.7m $5.3m $5.0m $3.9m
Tax Effect Of Unusual Items $0 $0 $0 $0 $0
Tax Provision $0 $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0 $0
Total change of marketable debt securities $215k ($119k) $7k
Total other comprehensive income (loss) $199k ($142k) $78k
Total Unusual Items $2.3m ($217k) $241k ($546k) ($546k)
Total Expenses $4.6m $5.6m $5.7m $11.0m $11.7m $9.8m $6.6m $6.6m
Total Other Finance Cost $12k ($37k) ($309k) ($309k)